Prevalence of restless legs syndrome in patients with irritable bowel syndrome

World Journal of Gastroenterology

Volumn 17, Issue 39, 2011, Pages 4404-4407

  Patrick Basu, P ^a,b,c   James Shah, N ^a   Krishnaswamy, Nithya ^a   Pacana, Tommy ^a  

^a Forest Hills Hospital   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c NEW YORK HOSPITAL QUEENS   (United States)

Author keywords

Irritable bowel syndrome; Prevalence; Restless legs syndrome; Small intestinal bacterial overgrowth

Indexed keywords

RIFAXIMIN; TANDOSPIRONE; TEGASEROD;

ADULT; ARTICLE; CONSTIPATION; DIARRHEA; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; PREVALENCE; QUESTIONNAIRE; RESTLESS LEGS SYNDROME;

EID: 81755162312     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i39.4404     Document Type: Article

References (27)

1. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am 2005; 34: 189-204
2. Andresen V, Camilleri M. Irritable bowel syndrome: recent and novel therapeutic approaches. Drugs 2006; 66: 1073-1088
3. Malagelada JR. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation. Int J Clin Pract 2006; 60: 57-63
4. Ringel Y, Sperber AD, Drossman DA. Irritable bowel syndrome. Annu Rev Med 2001; 52: 319-338
5. Lupascu A, Gabrielli M, Lauritano EC, Scarpellini E, San-toliquido A, Cammarota G, Flore R, Tondi P, Pola P, Gas-barrini G, Gasbarrini A. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 2005; 22: 1157-1160
6. Majewski M, McCallum RW. Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial. Adv Med Sci 2007; 52: 139-142
7. McCallum R, Schultz C, Sostarich S. Evaluating the role of small intestinal bacterial overgrowth (SIBO) in diarrhea predominant irritable bowel syndrome (IBS-D) patients utilizing the glucose breath test (GBT) [abstract T1118]. Gastroenterology 2005; 128 (4 suppl 2): A-460
8. Nucera G, Gabrielli M, Lupascu A, Lauritano EC, Santoliq-uido A, Cremonini F, Cammarota G, Tondi P, Pola P, Gasbarrini G, Gasbarrini A. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005; 21: 1391-1395
9. Pimentel M, Wallace D, Hallegua D, Chow E, Kong Y, Park S, Lin HC. A link between irritable bowel syndrome and fbromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis 2004; 63: 450-452
10. Sperber AD, Atzmon Y, Neumann L, Weisberg I, Shalit Y, Abu-Shakrah M, Fich A, Buskila D. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol 1999; 94: 3541-3546
11. Weinstock LB, Klutke CG, Lin HC. Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms. Dig Dis Sci 2008; 53: 1246-1251
12. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101-119
13. Rama AN, Kushida CA. Restless legs syndrome and periodic limb movement disorder. Med Clin North Am 2004; 88: 653-667
14. Satija P, Ondo WG Restless legs syndrome: pathophysiology, diagnosis and treatment. CNS Drugs 2008; 22: 497-518
15. Weinstock LB, Walters AS, Mullin GE, Duntley SP. Celiac disease is associated with restless legs syndrome. Dig Dis Sci 2010; 55: 1667-1673
16. Weinstock LB, Bosworth BP, Scherl EJ, Li E, Iroku U, Mun-sell MA, Mullen GE, Walters AS. Crohn's disease is associated with restless legs syndrome. Infamm Bowel Dis 2010; 16: 275-279
17. Weinstock LB. Antibiotic therapy may improve idiopathic restless legs syndrome: prospective, open-label pilot study of rifaximin, a no systemic antibiotic. Sleep Med 2010; 11: 427
18. Weinstock LB, Fern SE, Duntley SP. Restless legs syndrome in patients with irritable bowel syndrome: response to small intestinal bacterial overgrowth therapy. Dig Dis Sci 2008; 53: 1252-1256
19. Diagnostic classifcation of sleep and arousal disorders. 1979 first edition. Association of Sleep Disorders Centers and the Association for the Psychophysiological Study of Sleep. Sleep 1979; 2: 1-154
20. Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005; 21: 1365-1375
21. Rey E, García-Alonso MO, Moreno-Ortega M, Alvarez-Sanchez A, Diaz-Rubio M. Determinants of quality of life in irritable bowel syndrome. J Clin Gastroenterol 2008; 42: 1003-1009
22. Nicholl BI, Halder SL, Macfarlane GJ, Thompson DG, O'Brien S, Musleh M, McBeth J. Psychosocial risk markers for new onset irritable bowel syndrome--results of a large prospective population-based study. Pain 2008; 137: 147-155
23. Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology 1994; 107: 1040-1049
24. Kumar D, Thompson PD, Wingate DL, Vesselinova-Jenkins CK, Libby G. Abnormal REM sleep in the irritable bowel syndrome. Gastroenterology 1992; 103: 12-17
25. Larsson MH, Simrén M, Thomas EA, Bornstein JC, Lind-ström E, Sjövall H. Elevated motility-related transmucosal potential difference in the upper small intestine in the irritable bowel syndrome. Neurogastroenterol Motil 2007; 19: 812-820
26. Pimentel M, Soffer EE, Chow EJ, Kong Y, Lin HC. Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth. Dig Dis Sci 2002; 47: 2639-2643
27. Shioda K, Nisijima K, Yamauchi Y, Ohtuka K, Kato S. Use of a serotonin 1A receptor agonist to treat restless legs syndrome. J Clin Psychopharmacol 2006; 26: 673-675